‘Eris’ COVID Infections Increase as New COVID-19 Hospitalizations Decline
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
...
Submitted by mike kraft on
Submitted by mike kraft on
A large study from Singapore suggests that COVID-19 infection increased the risk of new-onset cardiovascular and cerebrovascular complications during the Delta variant era and that vaccination lowered the risk.
...
Submitted by mike kraft on
US COVID-19 hospitalizations and deaths continued their slow rise over the past week, but two early indicators showed declines, the Centers for Disease Control and Prevention (CDC) said in its latest data update.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.